Last update Oct23


Cantudo-Cuenca, M. R., Robustillo-Cortés, M. A., Cantudo-Cuenca, M. D., & Morillo-Verdugo, R. (2014). A better regulation is required in viral hepatitis smartphone applications. Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria38(2), 112–117.

CDA Foundation. (2023). CDA Foundation 2023 Global HCV Statistics.

CDC. (2020a). Hepatitis C Testing ServicesApril, 1–12.

CDC. (2020b, July 28). Definition of Hepatitis C.

Creative Commons. (2023). Creative Commons.

EMA. (2017). Maviret | European Medicines Agency.

FDA. (2017). FDA approves Mavyret for Hepatitis C | FDA.

Grebely, J., Dore, G. J., Morin, S., Rockstroh, J. K., & Klein, M. B. (2017). Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there. Journal of the International AIDS Society20(1).

Health, G., Strategy, S., Ending, T., & Hepatitis, V. (2021). Viral hepatitis 2016–2021June 2016.

hepatitisfoundation. (n.d.). hepatitis-c.

Jae Young Jang5, and D. Y. K. H. W. L. H. L. B. K. K. Y. C. (2022). Cost-effectiveness of chronic hepatitis C screening and treatment. Clinical and Molecular Hepatology28(16), 164–173.

Kim, D. Y., Yoon, K. T., Kim, W., Lee, J. Il, Hong, S. H., Lee, D., Jang, J. W., Choi, J. W., Kim, I., & Paik, Y. H. (2016). Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. Medicine95(30).

Lazarus, L., Patel, S., Shaw, A., Leblanc, S., Lalonde, C., Hladio, M., Mandryk, K., Horvath, C., Petrcich, W., Kendall, C., & Tyndall, M. W. (2016). Uptake of community-based peer administered HIV point-of-care testing: Findings from the PROUD study. PLoS ONE11(12), 1–11.

Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). “they look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal17(1), 1–9.

Paquette, C., Syvertsen, J., & Pollini, R. (2018). 乳鼠心肌提取 HHS Public Access. Physiology & Behavior176(5), 139–148.

Schwander, B., Feldstein, J., Sulo, S., Gonzalez, L., ElShishiney, G., & Hassany, M. (2022). Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program. Infectious Diseases and Therapy11(3), 1193–1203.

Spradling, P. R., Richardson, J. T., Buchacz, K., Moorman, A. C., Finelli, L., Bell, B. P., & Brooks, J. T. (2010). Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007. JAIDS Journal of Acquired Immune Deficiency Syndromes53(3), 388–396.

The Hepatitis Fund. (2023). The Hepatitis Fund.

Villena, E. Z. (2006). Transmission routes of hepatitis C virus infection. Annals of Hepatology5(SUPPL. 1), 12–14.


WHO. (2016). Global health sector strategy on viral hepatitis 2016-2021. Global Hepatitis Programme Department of HIV/AIDSJune, 56.

WHO. (2021). Tracking Universal Health Coverage: 2021 Global Monitoring Report. In Tracking Universal Health Coverage: 2017 Global Monitoring Report.

World Bank. (2015). New WHO and World Bank Group Report Shows that 400 Million Do Not Have Access to Essential Health Services and 6% of Population Tipped into or Pushed Further into Extreme Poverty because of Health Spending.

Zelenev, A., Li, J., Shea, P., Hecht, R., & Altice, F. L. (2021). Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States. Clinical Infectious Diseases72(5), 755–763.